PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Immunotherapy biomarkers

Original research

PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine

Online download statistics by month:

Online download statistics by month: October 2021 to March 2024

	Abstract	Full	Pdf
Oct 2021	731	732	218
Nov 2021	231	232	78
Dec 2021	123	123	62
Jan 2022	78	83	58
Feb 2022	56	59	50
Mar 2022	67	76	59
Apr 2022	75	78	52
May 2022	52	53	38
Jun 2022	65	65	37
Jul 2022	50	51	31
Aug 2022	73	75	43
Sep 2022	59	61	219
Oct 2022	60	61	25
Nov 2022	38	38	47
Dec 2022	44	44	29
Jan 2023	40	42	36
Feb 2023	68	68	21
Mar 2023	50	53	38
Apr 2023	23	23	16
May 2023	27	27	29
Jun 2023	28	28	20
Jul 2023	30	31	22
Aug 2023	29	29	13
Sep 2023	28	28	8
Oct 2023	21	21	16
Nov 2023	33	33	47
Dec 2023	44	44	14
Jan 2024	42	43	10
Feb 2024	35	35	18
Mar 2024	32	32	95
Total	2332	2368	1449